Zhang B, Liu H, Wu F, Ding Y, Wu J, Lu L
Front Pharmacol. 2024; 15:1359832.
PMID: 38650628
PMC: 11033397.
DOI: 10.3389/fphar.2024.1359832.
Li Y, Mao X, Li M, Li L, Tong X, Huang L
Clin Epigenetics. 2024; 16(1):16.
PMID: 38254153
PMC: 10802042.
DOI: 10.1186/s13148-024-01627-9.
Chatterjee K, Mal S, Ghosh M, Roy Chattopadhyay N, Roy S, Chakraborty K
Sci Rep. 2023; 13(1):22086.
PMID: 38086861
PMC: 10716134.
DOI: 10.1038/s41598-023-45001-w.
Chen S, Zhang L, Wang K, Huo J, Zhang S, Zhang X
Can J Gastroenterol Hepatol. 2023; 2023:5521544.
PMID: 37719132
PMC: 10505080.
DOI: 10.1155/2023/5521544.
Xu X, Chen J, Zhao H, Pi Y, Lin G, Hu L
Stem Cell Rev Rep. 2023; 19(7):2497-2509.
PMID: 37537495
DOI: 10.1007/s12015-023-10598-y.
PAK1 Mediates Bone Marrow Stromal Cell-Induced Drug Resistance in Acute Myeloid Leukemia via ERK1/2 Signaling Pathway.
Li B, Jia R, Zhou Y, Guo D, Teng Q, Du S
Front Cell Dev Biol. 2021; 9:686695.
PMID: 34307365
PMC: 8297649.
DOI: 10.3389/fcell.2021.686695.
MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism.
Ueda K, Kumari R, Schwenger E, Wheat J, Bohorquez O, Narayanagari S
Cancer Cell. 2021; 39(4):529-547.e7.
PMID: 33667384
PMC: 8575661.
DOI: 10.1016/j.ccell.2021.02.006.
P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer.
Yao D, Li C, Rajoka M, He Z, Huang J, Wang J
Theranostics. 2020; 10(21):9741-9766.
PMID: 32863957
PMC: 7449905.
DOI: 10.7150/thno.46913.
HLX affects cell cycle and proliferation in AML cells via the JAK/STAT signaling pathway.
Zhu X, Guo Q, Zhu M, Chen B, Wang L, Zhang D
Oncol Lett. 2020; 20(2):1888-1896.
PMID: 32724432
PMC: 7377103.
DOI: 10.3892/ol.2020.11718.
Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia.
Vu T, Straube J, Porter A, Bywater M, Song A, Ling V
Nat Commun. 2020; 11(1):3021.
PMID: 32541670
PMC: 7296000.
DOI: 10.1038/s41467-020-16840-2.
NKL homeobox gene activities in normal and malignant myeloid cells.
Nagel S, Scherr M, MacLeod R, Pommerenke C, Koeppel M, Meyer C
PLoS One. 2019; 14(12):e0226212.
PMID: 31825998
PMC: 6905564.
DOI: 10.1371/journal.pone.0226212.
Tumor suppressors BTG1 and BTG2: Beyond growth control.
Yuniati L, Scheijen B, Van der Meer L, van Leeuwen F
J Cell Physiol. 2018; 234(5):5379-5389.
PMID: 30350856
PMC: 6587536.
DOI: 10.1002/jcp.27407.
A metabolic interplay coordinated by HLX regulates myeloid differentiation and AML through partly overlapping pathways.
Piragyte I, Clapes T, Polyzou A, Geltink R, Lefkopoulos S, Yin N
Nat Commun. 2018; 9(1):3090.
PMID: 30082823
PMC: 6078963.
DOI: 10.1038/s41467-018-05311-4.
Selective dissociation between LSD1 and GFI1B by a LSD1 inhibitor NCD38 induces the activation of super-enhancer in erythroleukemia cells.
Yamamoto R, Kawahara M, Ito S, Satoh J, Tatsumi G, Hishizawa M
Oncotarget. 2018; 9(30):21007-21021.
PMID: 29765516
PMC: 5940392.
DOI: 10.18632/oncotarget.24774.
Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma.
Nagel S, Pommerenke C, Meyer C, Kaufmann M, MacLeod R, Drexler H
Oncotarget. 2018; 9(18):14338-14353.
PMID: 29581848
PMC: 5865674.
DOI: 10.18632/oncotarget.24512.
Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia.
Aziz H, Ping C, Alias H, Mutalib N, Jamal R
Front Pharmacol. 2017; 8:897.
PMID: 29270125
PMC: 5725465.
DOI: 10.3389/fphar.2017.00897.
Transcriptome analysis and identification of significantly differentially expressed genes in Holstein calves subjected to severe thermal stress.
Srikanth K, Lee E, Kwan A, Lim Y, Lee J, Jang G
Int J Biometeorol. 2017; 61(11):1993-2008.
PMID: 28900747
DOI: 10.1007/s00484-017-1392-3.
The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation.
Mizukawa B, OBrien E, Moreira D, Wunderlich M, Hochstetler C, Duan X
Blood. 2017; 130(11):1336-1346.
PMID: 28778865
PMC: 5600140.
DOI: 10.1182/blood-2016-12-758458.
ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia.
Wan L, Wen H, Li Y, Lyu J, Xi Y, Hoshii T
Nature. 2017; 543(7644):265-269.
PMID: 28241141
PMC: 5372383.
DOI: 10.1038/nature21687.
Stem and progenitor cell alterations in myelodysplastic syndromes.
Shastri A, Will B, Steidl U, Verma A
Blood. 2017; 129(12):1586-1594.
PMID: 28159737
PMC: 5364336.
DOI: 10.1182/blood-2016-10-696062.